Modernize Testing | Eliminate animal testing in FDA approval process

FDA Announcement on Phasing Out Animal Testing a Remarkable Turnaround

U.S. Senate Passes FDA Modernization Act 3.0, Sends Urgent Measure to House for Final Action

Is DOGE the Swan Song for Animal Testing?

FDA and Animal-Testing Industry Want to Keep Animal Testing Trade Brisk, No Matter the Costs to Animals and to Patients in Need

Read here

U.S. Senators Tell FDA to Move Beyond Animal Tests Toward Better, More Humane Methods

Read here

Latest News

On The 46th World Day for Animals in Laboratories, FDA’s Roadmap to Phase Out Animal Testing is Celebrated

April 24, 2025

FDA’s Roadmap to Phase Out Animal Testing Will Create a More Humane, Scientifically Rigorous, and Efficient Health Delivery Model for the Nation

April 15, 2025

Tell your legislators

to support the FDA Modernization Act 3.0 to stop the FDA from causing the needless torment of beagles, primates and other animals in new drug approvals.

Here

FDA Must Take Immediate Steps to Implement the
FDA Modernization Act 3.0

The Food Drug and Cosmetics Act was amended in 2022 to allow for human-relevant nonanimal test methods, lifting the mandate for animal testing.

The current state

Outdated Regulations

FDA must initiate rulemaking so outdated regulations comport with the revised statute and Congressional intent.

Deliberate Ambiguity at FDA

Current FDA programs to evaluate and accept nonanimal test methods are vague, ineffective, top-heavy, and lack transparency, failing to set up the agency or drug developers for success. FDA must end its deliberate ambiguity practice regarding the use of animals in preclinical research.

the path forward

Regulatory Clarity

FDA must create a clear pathway for regulatory acceptance of nonanimal test methods.

Break the status quo

FDA must act expeditiously to change the drug development paradigm as Congress intended. Otherwise, the 90 to 95% failure rate in clinical trials of drugs that pass animal tests for safety and efficacy fail in human trials will continue.

Read our Fact Sheet

on the FDA Modernization Act 3.0

HERE